The over the counter (OTC) drugs global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Over The Counter (OTC) Drugs Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size – The over the counter (OTC) drugs market size has grown strongly in recent years. It will grow from $149.57 billion in 2023 to $158.26 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to regulatory changes, consumer awareness, healthcare accessibility, demographic trends, and economic factors.
The over the counter (OTC) drugs market size is expected to see strong growth in the next few years. It will grow to $199.99 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to increasing self-medication practices, expanding retail distribution channels, chronic disease burden, product innovation, and global health trends. Major trends in the forecast period include rising demand for natural and herbal remedies, expansion of e-commerce platforms, personalized medicine and targeted therapies, emphasis on preventive healthcare, and integration of digital health technologies.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/over-the-counter-otc-drugs-global-market-report
Scope Of Over The Counter (OTC) Drugs Market
The Business Research Company’s reports encompass a wide range of information, including:
- Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
- Drivers: Examination of the key factors propelling market growth.
- Trends: Identification of emerging trends and patterns shaping the market landscape.
- Key Segments: Breakdown of the market into its primary segments and their respective performance.
- Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
- Macro Economic Factors: Assessment of broader economic elements impacting the market.
Over The Counter (OTC) Drugs Market Overview
Market Drivers – The increasing prevalence of lifestyle-related health issues is expected to propel the growth of the over-the-counter (OTC) drugs market going forward. Lifestyle-related health issues refer to medical conditions or ailments primarily influenced by an individual’s habits, behaviors, and choices in areas such as diet, physical activity, substance use, and stress management. The increasing prevalence of lifestyle-related health issues is due to sedentary lifestyles, unhealthy dietary habits, smoking, excessive alcohol consumption, and rising levels of stress in modern society. Over-the-counter (OTC) drugs can play a significant role in managing lifestyle-related health issues by providing convenient, accessible, and effective treatments for common conditions associated with modern living. For instance, in March 2022, according to the World Health Organization, a Switzerland-based intergovernmental organization, about 1 billion people globally were obese, which includes 650 million adults, 340 million teenagers, and 39 million children. The prevalence of obesity is on the rise, and by 2025, it is projected that 167 million adults and children will suffer health consequences due to being overweight or obese. Furthermore, in 2021, according to the International Diabetes Federation, a Belgium-based organization, the projected number of individuals living with diabetes is expected to increase to 643 million by 2030 and 783 million by 2045. Therefore, the increasing prevalence of lifestyle-related health issues is driving the growth of the over-the-counter (OTC) drugs market.
Market Trends – Major companies operating in the over-the-counter drug market are developing innovative products, such as over-the-counter sprays, to gain a competitive edge in the market. Over-the-counter (OTC) sprays are convenient, easy-to-use medications that deliver therapeutic agents directly to specific areas of the body. For instance, in August 2023, Emergent BioSolutions Inc., a US-based biotechnology company, launched its over-the-counter NARCAN Naloxone HCl Nasal Spray 4 mg. This nasal spray provides an effective means of reversing opioid effects, including those of potent synthetic opioids like fentanyl. Its user-friendly design ensures quick and straightforward administration, even by individuals without medical training, facilitating rapid emergency response.
The over the counter (OTC) drugs market covered in this report is segmented –
- By Product Type: Cough, Cold And Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral And Supplements (VMS), Weight Loss Or Dietary Products, Ophthalmic Products, Sleeping Aids, Other Product Types
- By Formulation Type: Tablets, Liquids, Ointments, Sprays
- By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Channels
- By End-Users: Specialty Clinics, Homecare, Hospitals, Other End Users
Get an inside scoop of the over the counter (otc) drugs market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15630&type=smp
Regional Insights – North America was the largest region in the over the counter (OTC) drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the over the counter (OTC) drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies – Major companies operating in the over the counter (OTC) drugs market are Pfizer Inc., Johnson & Johnson Private Limited, The Procter & Gamble Company, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Ltd., Novo Nordisk A/S, Reckitt Benckiser Group PLC, Viatris Inc., Teva Pharmaceutical Industries Ltd., DAIICHI SANKYO COMPANY LIMITED, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Perrigo Company plc, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Alkem Laboratories Limited, Piramal Enterprises Ltd.
Table of Contents
- Executive Summary
- Over The Counter (OTC) Drugs Market Report Structure
- Over The Counter (OTC) Drugs Market Trends And Strategies
- Over The Counter (OTC) Drugs Market – Macro Economic Scenario
- Over The Counter (OTC) Drugs Market Size And Growth
… - Over The Counter (OTC) Drugs Market Competitor Landscape And Company Profiles
- Key Mergers And Acquisitions
- Future Outlook and Potential Analysis
- Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
